NASDAQ | ETF
The fund normally invests at least 80% of assets in securities of disruptive medicine companies.
Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers.
Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time.
The fund is non-diversified.
Top 18 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 6.60% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 5.17% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 4.27% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.96% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.67% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 3.61% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 3.47% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.35% |
| CNC | Centene Corp | Healthcare | Healthcare Plans | 3.15% |
| BRKR | Bruker Corporation | Healthcare | Medical Devices | 3.01% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.97% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 2.82% |
| INSP | Inspire Medical Systems Inc | Healthcare | Medical Devices | 2.77% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.76% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.68% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 2.59% |
| PEN | Penumbra Inc | Healthcare | Medical Devices | 2.55% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 2.41% |